Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
CN Stock MarketDetailed Quotes
300006 Chongqing Lummy Pharmaceutical
- 3.47
- -0.05-1.42%
Market Closed Jan 22 15:00 CST
3.66BMarket Cap192.78P/E (TTM)
3.51High3.43Low142.76KlotVolume3.50Open3.52Pre Close49.44MTurnover1.35%Turnover RatioLossP/E (Static)1.06BShares6.4352wk High1.78P/B3.66BFloat Cap2.0352wk Low4.22Limit Up1.06BShs Float21.82Historical High2.82Limit Down2.27%Amplitude2.03Historical Low--Dividend TTM3.46Avg Price68.83KlotAsk--Div YieldTTM100Lot Size68.65KlotBid
Chongqing Lummy Pharmaceutical News
Laimei Pharmaceuticals: 2024 performance forecast
Laimei Pharmaceuticals: Announcement on Abnormal Fluctuations in Stock Trading
Laimei Pharmaceutical: Announcement on the progress of the controlling shareholder\'s agreement to transfer part of the company\'s shares to the transferee
Laimei Pharmaceutical: Announcement of Resolutions of the 41st Meeting of the Fifth Board of Directors
Laimei Pharmaceutical: Announcement on guaranteeing financing and credit for Chongqing Laimei Longyu Pharmaceutical Co., Ltd.
Laimei Pharmaceutical: Announcement of Resolutions of the 35th Meeting of the Fifth Board of Supervisors
Laimei Pharmaceutical: Announcement on the results of the first instance judgment on the wholly-owned subsidiary lawsuit
Laimei Pharmaceutical: Announcement on participating in the tenth batch of national centralized drug procurement to be selected
Laimei Pharmaceutical: Announcement on the Controlling Shareholder\'s Proposed Agreement to Transfer Part of the Company\'s Shares
Laimei Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Chongqing Laimei Pharmaceutical Co., Ltd.
Laimei Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Laimei Pharmaceutical: Announcement on the inclusion of the company\'s products in the medical insurance catalogue
Laimei Pharmaceuticals: Prompt Notice on Disclosure of Simplified Equity Change Report
Laimei Pharmaceuticals: Laimei Pharmaceuticals Simplified Equity Change Report
Laimei Pharmaceutical: Proposed changes in the controlling shareholder and actual controller of the company
Laimei Pharmaceuticals: Notice on Obtaining Approval Notice for Drug Supplemental Applications
Laimei Pharmaceutical: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Chongqing
Laimei Pharmaceutical: Announcement of Resolutions of the 34th Meeting of the Fifth Board of Supervisors
Laimei Pharmaceuticals: Announcement on the proposed change of accounting firm
Laimei Pharmaceutical: Announcement of Resolutions of the 40th Meeting of the Fifth Board of Directors